beta-ESCIN

Base Information

• Chemical Name: beta-ESCIN
• CAS No.: 11072-93-8
• Molecular Formula: C55H86O24
• Molecular Weight: 1101.38
• Hs Code.: 2938900000
• European Community (EC) Number: 229-880-6,247-619-4,600-985-2
• UNII: QYK0D6H79O
• DSSTox Substance ID: DTXSID601026279
• Wikipedia: Aescin
• Wikidata: Q27895506
• Metabolomics Workbench ID: 140301
• ChEMBL ID: CHEMBL505939
• Mol file: 11072-93-8.mol

Synonyms:escin Ib;escin-IIb

Chemical Property of beta-ESCIN

Chemical Property:

• Appearance/Colour: white powder
• Vapor Pressure: 0mmHg at 25°C
• Melting Point: 222-223°
• Refractive Index: 1.627
• Boiling Point: 1140.642 °C at 760 mmHg
• Flash Point: 311.842 °C
• PSA: 0.00000
• Density: 1.467 g/cm³
• LogP: 1.02620
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• XLogP3: 0.7
• Hydrogen Bond Donor Count: 13
• Hydrogen Bond Acceptor Count: 24
• Rotatable Bond Count: 16
• Exact Mass: 1130.55090361
• Heavy Atom Count: 79
• Complexity: 2300

Purity/Quality:

98%,99%, ^*data from raw suppliers

b-Aescin ^*data from reagent suppliers

Safty Information:

• Pictogram(s): Xn
• Hazard Codes: Xn
• Statements: 22
• Safety Statements: 22-24/25

MSDS Files:

SDS file from LookChem

Useful:

• Chemical Classes: Biological Agents -> Plant Oils and Extracts
• Canonical SMILES: CC=C(C)C(=O)OC1C(C2(C(CC1(C)C)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)CO)OC6C(C(C(C(O6)C(=O)O)OC7C(C(C(C(O7)CO)O)O)O)O)OC8C(C(C(C(O8)CO)O)O)O)C)CO)OC(=O)C
• Isomeric SMILES: C/C=C(/C)\C(=O)O[C@H]1[C@@H]([C@@]2([C@@H](C[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H]([C@]5(C)CO)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C)C)[C@@H]2CC1(C)C)C)O)CO)OC(=O)C
• Recent ClinicalTrials: Escin in Patients With Covid-19 Infection
• Recent EU Clinical Trials: A phase IIa, single-center, randomized, reference-controlled, observer-blind trial to assess the efficacy of a topical Aescin formulation in experimentally induced itch, wheal and flare reactions in patients with type-I allergy
• Uses: Peripheral vascular disorders Escin has been used as a treatment for ischemic damage, hemorrhoids, and trauma or for recovery post-operation. Also used in the treatment of adenocarcinoma cell lines.